Analysts predict slower initial sales for the Alzheimer’s medication Leqembi

Jay Reinstein, an individual suffering from Alzheimer’s, recently underwent a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023, after receiving an injection. Image Credit: Michael Robinson Chávez | The Washington Post | Getty Images Analysts predict that sales of the Alzheimer’s drug Leqembi may start off slow due to …

Read more

Approval of Alzheimer’s drug unlikely to alleviate coverage tensions

Medicare officials, Alzheimer’s patient groups, and lawmakers are embroiled in an ongoing dispute over coverage of a newly approved Alzheimer’s drug, despite the drug receiving the green light from federal health officials. The Food and Drug Administration (FDA) granted full approval to the drug, Leqembi, based on clinical trial data that demonstrated a 27% reduction …

Read more

Move Over, Joe Biden – The Atlantic

I am incredibly thankful to Joe Biden for his victory over Donald Trump in 2020. He saved our country from the destructive rule of a dangerous con artist and chronic liar. Trump was consumed by vindictiveness, disregard for the law, and an insatiable ego. In stark contrast, Biden presented himself as a decent, experienced, and …

Read more

First Alzheimer’s Therapy Proven to Slow Cognitive Decline Receives FDA Approval

The Food and Drug Administration (FDA) has granted full approval to the first Alzheimer’s drug that has been proven to moderately slow the progression of the disease. The approval is based on clinical trial data showing that Leqembi reduces cognitive decline by approximately 27% compared to a placebo in patients with early-stage Alzheimer’s. Teresa Buracchio, …

Read more

Leqembi, an Alzheimer’s drug from Eisai and Biogen, receives FDA approval

The Food and Drug Administration (FDA) granted full approval to Leqembi, an Alzheimer’s treatment, on Thursday. This milestone decision will increase accessibility to the costly drug for older Americans. Shortly after the FDA’s approval, Medicare announced that it will now provide coverage for the antibody treatment to patients enrolled in the senior insurance program, with …

Read more

New Study Reveals Stage 3 CTE Diagnosis in the Late Montreal Canadiens Legend Henri Richard at Time of Death

By Staff The Canadian Press Posted June 14, 2023 1:38 pm Updated June 14, 2023 1:45 pm Decrease article font size Increase article font size Hockey Hall of Famer and Montreal Canadiens great Henri Richard has been posthumously diagnosed with stage 3 chronic traumatic encephalopathy (CTE), as announced by the Concussion Legacy Foundation Canada on …

Read more

Leqembi, an Alzheimer’s drug, receives support from FDA advisors and is on track for complete approval.

Eisai and Biogen’s drug Leqembi, aimed at treating Alzheimer’s, has received unanimous support from a panel of independent advisors to the Food and Drug Administration (FDA), indicating full approval is expected this summer. The advisors voted 6-0 in success of Eisai’s data, which showed a substantial clinical benefit for patients. While the FDA is not …

Read more